痴呆或衰弱患者接受大截肢后结局不良
基于2016年1月1日至2020年12月31日美国联邦医疗保险按服务付费索赔数据,纳入46930例因慢性肢体威胁性缺血(CLTI)行踝部或以上大截肢的患者,其中11465例(24.4%)有阿尔茨海默病及相关痴呆(ADRD),24790例(52.8%)有衰弱。衰弱/ADRD组(n=10153)1年死亡率为55.3%,30天再入院率为29.6%,1年内截肢翻修/再手术率为32.3%;四组中仅1年死亡率以衰弱/ADRD组最差。
要点
- 46930例大截肢患者中,ADRD占24.4%,衰弱占52.8%,55.9%的截肢为膝下截肢。
- 衰弱/ADRD组(n=10153)1年死亡率55.3%,30天再入院率29.6%,1年内翻修/再手术率32.3%。
- 四组中仅1年死亡率以衰弱/ADRD组最差,衰弱比ADRD更常与任一结局的最差结果相关。
核心结论
- 因CLTI行大截肢的ADRD或中度/重度衰弱患者经历一系列极差结局,包括高死亡率、再入院、翻修及出院至更高级别照护的风险。
- 结局严重程度与ADRD/衰弱状态之间的关系复杂,衰弱比ADRD更常与任一给定结局的最差结果相关。
- 这些数据为帮助决策与医疗价值观和目标相一致提供了重要结局信息。
研究设计与样本
- 基于2016年1月1日至2020年12月31日美国联邦医疗保险按服务付费索赔数据的分析。
- 纳入因CLTI行踝部或以上截肢的患者,共46930例。
- 使用基于索赔的衰弱指数测量衰弱,将痴呆和衰弱二分为非衰弱(前衰弱/健壮)与衰弱(中度/重度),形成四组:非衰弱/非ADRD、衰弱/非ADRD、非衰弱/ADRD、衰弱/ADRD。
- 采用广义估计方程进行线性与逻辑回归,并对选定结局以死亡作为竞争风险进行分析。
主要发现
- 46930例大截肢患者中,11465例(24.4%)有ADRD,24790例(52.8%)有衰弱。
- 总体55.9%的截肢为膝下截肢。
- 衰弱/ADRD组(n=10153)1年死亡率为55.3%,30天再入院率为29.6%,1年内截肢翻修/再手术率为32.3%。
- 四组中仅1年死亡率以衰弱/ADRD组最差。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Major lower limb amputation is a disfiguring operation associated with impaired mobility and high near-term mortality. Informed decision-making regarding amputation requires outcomes data. Despite the co-occurrence of both chronic limb-threatening ischemia (CLTI) and Alzheimer's disease and related dementias (ADRD), there is sparse data on the outcomes of major limb amputation in this population and the impact of frailty. We sought to determine mortality, complications, readmissions, revisions, intensive interventions (eg, cardiopulmonary resuscitation), and other outcomes after amputation for CLTI in patients living with ADRD looking at the modifying effects of frailty. METHODS: We examined Medicare fee-for-service claims data from January 1, 2016, to December 31, 2020. Patients with CLTI undergoing amputation at or proximal to the ankle were included. Along with demographic information, dementia status, and comorbid conditions, we measured frailty using a claims-based frailty index. We dichotomized dementia and frailty (pre-frail/robust = "non-frail" vs moderate/severe frailty = "frail") to create four groups: non-frail/non-ADRD, frail/non-ADRD, non-frail/ADRD, and frail/ADRD. We used linear and logistic regression via generalized estimating equations in addition to performing selected outcomes analyses with death as a competing risk to understand the association between dementia status, frailty status, and 1-year mortality as our primary outcome in addition to the postoperative outcomes outlined above. RESULTS: Among 46,930 patients undergoing major limb amputation, 11,465 (24.4%) had ADRD and 24,790 (52.8%) had frailty. Overall, 55.9% of amputations were below-knee. Selected outcomes among frail/ADRD patients undergoing amputation (n = 10,153) were: 55.3% 1-year mortality 29.6% readmissions at 30 days, and 32.3% amputation revision/reoperation within 1 year. Of all four groups, those in the frail/ADRD had the worst outcomes only for 1-year mortality. CONCLUSIONS: First, patients with ADRD or moderate/severe frailty suffer an array of very poor outcomes after major limb amputation for CLTI, including high mortality, readmissions, revision, and risks of discharge to higher levels of care. Second, there is a complex relationship between outcome severity and ADRD/frailty status. Specifically, frailty is more often than ADRD associated with the poorest results for any given outcome. These data provide important outcomes data to help align decision-making with health care values and goals.
引用
- Shah SK, Xiang L, Adler RR, et al. Patients with dementia or frailty undergoing major limb amputation have poor outcomes. J Vasc Surg. 2024. PMID: 39226934. doi:10.1016/j.jvs.2024.08.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。